Relationship Between CIP2A and Endometrium Cancer

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• Endometrial cancer is a significant gynecological malignancy.
• The role of oncoproteins in endometrial cancer progression is an area of active research.
• Cancerous inhibitor of protein phosphatase 2A (CIP2A) is implicated in various cancers.

Purpose of the Study:

• To investigate the relationship between CIP2A expression and endometrial cancer.
• To evaluate the correlation of CIP2A with clinicopathological prognostic parameters.
• To explore the association of CIP2A with other biomarkers like Ki67, P53, and HER2.

Main Methods:

• Immunohistochemical and molecular analyses of CIP2A expression in endometrial tissues.
• Correlation analysis between CIP2A levels and endometrial pathologies.
• Investigation of CIP2A association with prognostic factors and biomarkers.

Main Results:

• Significantly higher CIP2A expression was observed in endometrial cancer tissues compared to normal tissues.
• CIP2A expression positively correlated with advanced FIGO Stage, Grade, cervical involvement, and myometrial invasion.
• CIP2A levels were associated with HER2 positivity.

Conclusions:

• CIP2A is upregulated in endometrial cancer and linked to adverse prognostic indicators.
• CIP2A represents a potential therapeutic target for endometrial cancer.
• Further research into CIP2A's interactions may advance early diagnosis and treatment strategies.